“We were pleased with the...

“We were pleased with the results so much….that we will continue [the study] in the future. We wanted to see [whether] educating members about opioids and safe use of those opioids would result in positive outcomes, and it did.”   —Cynthia Griffin, Pharm.D., Florida Blue’s vice president for Medicare pharmacy programs, spoke with AIS’s Radar on Medicare Advantage about the insurer’s opioid pilot partnership with Prime Therapeutics, and how the two orgs worked to prevent opioid misuse among seniors.

 

Subscribers may read the Radar on Medicare Advantage article in which this quote appeared online. Learn more about subscribing to AIS Health's publications.    SHAPE  \* MERGEFORMAT